169 related articles for article (PubMed ID: 33855736)
1. A prospective, real-world, clinical pharmacokinetic study to inform lacosamide dosing in critically ill patients undergoing continuous venovenous haemofiltration (PADRE-02).
Kalaria SN; Armahizer M; McCarthy P; Badjatia N; Gobburu JV; Gopalakrishnan M
Br J Clin Pharmacol; 2021 Nov; 87(11):4375-4385. PubMed ID: 33855736
[TBL] [Abstract][Full Text] [Related]
2. A Practice-Based, Clinical Pharmacokinetic Study to Inform Levetiracetam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration (PADRE-01).
Kalaria SN; Armahizer M; McCarthy P; Badjatia N; Gobburu JV; Gopalakrishnan M
Clin Transl Sci; 2020 Sep; 13(5):950-959. PubMed ID: 32223067
[TBL] [Abstract][Full Text] [Related]
3. Optimizing ceftaroline dosing in critically ill patients undergoing continuous renal replacement therapy.
Kalaria S; Williford S; Guo D; Shu Y; Medlin C; Li M; Yeung SYA; Ali F; Jean W; Gopalakrishnan M; Heavner M
Pharmacotherapy; 2021 Feb; 41(2):205-211. PubMed ID: 33438291
[TBL] [Abstract][Full Text] [Related]
4. Lacosamide Pharmacokinetics in a Critically Ill Patient Receiving Continuous Venovenous Hemofiltration.
Franquiz MJ; Kalaria SN; Armahizer MJ; Gopalakrishnan M; McCarthy PJ; Badjatia N
Pharmacotherapy; 2018 Feb; 38(2):e17-e21. PubMed ID: 29160945
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and Pharmacodynamics of Extended-Infusion Cefepime in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective, Open-Label Study.
Philpott CD; Droege CA; Droege ME; Healy DP; Courter JD; Ernst NE; Harger NJ; Foertsch MJ; Winter JB; Carter KE; Van Fleet SL; Athota K; Mueller EW
Pharmacotherapy; 2019 Nov; 39(11):1066-1076. PubMed ID: 31549737
[TBL] [Abstract][Full Text] [Related]
6. Lacosamide Pharmacokinetics in a Critically Ill Patient During Continuous Renal Replacement Therapy.
Wieruszewski PM; Lopez-Ruiz A; Albright RC; Fugate JE; Barreto EF
J Pharm Pract; 2020 Jun; 33(3):395-398. PubMed ID: 30336720
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of polymyxin B in critically ill patients receiving continuous venovenous haemofiltration.
Wang P; Xing H; Zhang F; Liu S; Lu Y; Zhang X; Yang J; Sun T
Int J Antimicrob Agents; 2022 Jul; 60(1):106599. PubMed ID: 35526750
[TBL] [Abstract][Full Text] [Related]
8. Impact of renal replacement modalities on the clearance of piperacillin-tazobactam administered via continuous infusion in critically ill patients.
Roger C; Cotta MO; Muller L; Wallis SC; Lipman J; Lefrant JY; Roberts JA
Int J Antimicrob Agents; 2017 Aug; 50(2):227-231. PubMed ID: 28689876
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration.
Jamal JA; Mat-Nor MB; Mohamad-Nor FS; Udy AA; Wallis SC; Lipman J; Roberts JA
Int J Antimicrob Agents; 2015 Jan; 45(1):41-5. PubMed ID: 25455853
[TBL] [Abstract][Full Text] [Related]
10. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion versus intermittent bolus administration.
Jamal JA; Roberts DM; Udy AA; Mat-Nor MB; Mohamad-Nor FS; Wallis SC; Lipman J; Roberts JA
Int J Antimicrob Agents; 2015 Jul; 46(1):39-44. PubMed ID: 25881872
[TBL] [Abstract][Full Text] [Related]
12. Population Pharmacokinetics of Cefuroxime in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration With Regional Citrate Anticoagulation and a Phosphate-Containing Replacement Fluid.
Janssen PK; Foudraine NA; Burgers DM; Neef K; le Noble JL
Ther Drug Monit; 2016 Dec; 38(6):699-705. PubMed ID: 27494946
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of cefoperazone/sulbactam in critically ill patients receiving continuous venovenous hemofiltration.
Gao C; Tong J; Yu K; Sun Z; An R; Du Z
Eur J Clin Pharmacol; 2016 Jul; 72(7):823-30. PubMed ID: 27023465
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and dialytic clearance of apixaban during in vitro continuous renal replacement therapy.
Andrews L; Benken S; Tan X; Wenzler E
BMC Nephrol; 2021 Jan; 22(1):45. PubMed ID: 33516188
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration.
Radej J; Krouzecky A; Stehlik P; Sykora R; Chvojka J; Karvunidis T; Novak I; Matejovic M
Ther Drug Monit; 2011 Aug; 33(4):393-7. PubMed ID: 21654349
[TBL] [Abstract][Full Text] [Related]
16. Development and Use of an Ex-Vivo In-Vivo Correlation to Predict Antiepileptic Drug Clearance in Patients Undergoing Continuous Renal Replacement Therapy.
Kalaria SN; Armahizer M; McCarthy P; Badjatia N; Gobburu JV; Gopalakrishnan M
Pharm Res; 2022 May; 39(5):827-836. PubMed ID: 35552966
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
Boereboom FT; Ververs FF; Blankestijn PJ; Savelkoul TJ; van Dijk A
Intensive Care Med; 1999 Oct; 25(10):1100-4. PubMed ID: 10551965
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of zanamivir in critically ill patients undergoing continuous venovenous hemofiltration.
Wieringa A; Ter Horst PG; Wagenvoort GH; Koch BC; Haringman JJ
Antivir Ther; 2023 Feb; 28(1):13596535221150746. PubMed ID: 36609161
[TBL] [Abstract][Full Text] [Related]
19. Aminoglycoside Pharmacokinetics in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.
Krueger CK; Bruno JJ; Tverdek FP; Hernandez M; Abudayyeh A
Ann Pharmacother; 2023 Jun; 57(6):629-636. PubMed ID: 36062536
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy.
Wenzler E; Butler D; Tan X; Katsube T; Wajima T
Clin Pharmacokinet; 2022 Apr; 61(4):539-552. PubMed ID: 34792787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
